Amgen buys Micromet for anti-leukemia drug – AFP
 AFP | Amgen buys Micromet for anti-leukemia drug AFP WASHINGTON — Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy. Amgen said it would pay $1.16 billion for Micromet, founded by a team of German ... Amgen buys drug developer Micromet for $1.16 billion Amgen to buy Micromet for $1.2 billion 2 Biotech Firms Bolster Their Drug Pipelines Through Deals |
Short URL: http://breakingnewsdaily.com/?p=7567
Posted by Business - Google News
on Jan 26 2012. Filed under Business.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
